Education
About Us
Working with TipRanks
Follow Us
bioAffinity Technologies, Inc. (BIAF)
NASDAQ:BIAF
Total Valuation
bioAffinity Technologies, Inc. has a market cap or net worth of $10.93M. The enterprise value is $5.64M.
Market Cap$10.93M
Enterprise Value$5.64M
Share Statistics
bioAffinity Technologies, Inc. has 4,498,675 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,498,675
Owned by Insiders―
Owned by Institutions0.25%
Financial Efficiency
bioAffinity Technologies, Inc.’s return on equity (ROE) is -2.05 and return on invested capital (ROIC) is -125.29%.
Return on Equity (ROE)-2.05
Return on Assets (ROA)-1.36
Return on Invested Capital (ROIC)-125.29%
Return on Capital Employed (ROCE)-1.31
Revenue Per Employee108.10K
Profits Per Employee-261.57K
Employee Count57
Asset Turnover0.56
Inventory Turnover88.36
Valuation Ratios
The current PE Ratio of bioAffinity Technologies, Inc. is ―. bioAffinity Technologies, Inc.’s PEG ratio is 0.00221.
PE Ratio―
PS Ratio0.33
PB Ratio0.28
Price to Fair Value0.28
Price to FCF-0.22
Price to Operating Cash Flow-0.50
PEG Ratio0.00221
Income Statement
In the last 12 months, bioAffinity Technologies, Inc. had revenue of 6.16M and earned -14.91M in profits. Earnings per share was -8.66.
Revenue6.16M
Gross Profit1.43M
Operating Income-10.57M
Pretax Income-14.87M
Net Income-14.91M
EBITDA-10.07M
Earnings Per Share (EPS)-8.66
Cash Flow
In the last 12 months, operating cash flow was -9.33M and capital expenditures 0.00, giving a free cash flow of -9.33M billion.
Operating Cash Flow-9.33M
Free Cash Flow-9.33M
Free Cash Flow per Share-2.07
Dividends & Yields
bioAffinity Technologies, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-3.34
52-Week Price Change-71.74%
50-Day Moving Average1.23
200-Day Moving Average4.34
Relative Strength Index (RSI)69.89
Average Volume (3m)5.91M
Important Dates
bioAffinity Technologies, Inc. upcoming earnings date is May 20, 2026, Before Open (Confirmed).
Last Earnings DateMar 13, 2026
Next Earnings DateMay 20, 2026
Ex-Dividend Date―
Financial Position
bioAffinity Technologies, Inc. as a current ratio of 2.60, with Debt / Equity ratio of 15.95%
Current Ratio2.60
Quick Ratio2.58
Debt to Market Cap0.57
Net Debt to EBITDA0.53
Interest Coverage Ratio-238.27
Taxes
In the past 12 months, bioAffinity Technologies, Inc. has paid 44.04K in taxes.
Income Tax44.04K
Effective Tax Rate>-0.01
Enterprise Valuation
bioAffinity Technologies, Inc. EV to EBITDA ratio is 0.32, with an EV/FCF ratio of 0.35.
EV to Sales-0.53
EV to EBITDA0.32
EV to Free Cash Flow0.35
EV to Operating Cash Flow0.35
Balance Sheet
bioAffinity Technologies, Inc. has $6.45M in cash and marketable securities with $1.16M in debt, giving a net cash position of $5.29M billion.
Cash & Marketable Securities$6.45M
Total Debt$1.16M
Net Cash$5.29M
Net Cash Per Share$1.18
Tangible Book Value Per Share$3.00
Margins
Gross margin is 23.21%, with operating margin of -171.58%, and net profit margin of -241.96%.
Gross Margin23.21%
Operating Margin-171.58%
Pretax Margin-241.25%
Net Profit Margin-241.96%
EBITDA Margin-163.38%
EBIT Margin-171.58%
Analyst Forecast
The average price target for bioAffinity Technologies, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-27.66%
EPS Growth Forecast13.18%